Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer

The Hill

BY JORDAN WILLIAMS – 09/17/21 09:28 PM EDT

Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer.

In a notice posted to the Food and Drug Administration’s (FDA) website on Thursday, Pfizer said it was recalling Chantix 0.5 mg and 1 mg tablets to the consumer level due to the presence of N-nitroso-varenicline.

Read more…